Literature DB >> 27312558

Presence of Additional Cytogenetic Abnormality of t(1;15) at Diagnosis of Chronic Myelogenous Leukemia-Chronic Phase.

Misuk Ji1, Mina Hur2, Hyeong Nyeon Kim1, Hee-Won Moon1, Yeo-Min Yun1, Sung-Yong Kim3, Sung-Hee Han4.   

Abstract

At diagnosis, fewer than 10% of chronic myelogenous leukemia (CML) patients have additional cytogenetic abnormalities (ACAs), which are frequently found in transformation to blast crisis. We report a case of CML-chronic phase (CML-CP) that showed t(1;15) at diagnosis. A 64-year-old man presented with sustained leukocytosis and thrombocytosis. His bone marrow (BM) was hypercellular with 2.5% blasts and BCR-ABL1 rearrangement. The karyotype in the BM was 46,XY,t(1;15)(q32;p13),t(9;22)(q34;q11.2)[20], while the karyotype in the peripheral blood was 46,XY[20]. This is the first report on the presence of t(1;15) at diagnosis of CML-CP, and its clinical significance remains unclear.
© 2016 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  additional cytogenetic abnormality; chronic myelogenous leukemia; chronic phase; diagnosis; t(1; 15)

Mesh:

Year:  2016        PMID: 27312558

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

Review 1.  [Acute myeloid leukemia with FIP1L1-PDGFRA fusion gene treated with imatinib: a case report and literature review].

Authors:  J C Fan; W W You; H X Liu; Y Cai; X Du; J X Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.